Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Head Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00623831
What this trial is testing

Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen

Who this might be right for
MelanomaSarcomaGastrointestinal Stromal Tumor (GIST)+6 more
Ludwig Institute for Cancer Research 17
Testing effectiveness (Phase 2)Ended earlyNCT02924675
What this trial is testing

Interest of Pregabalin (Lyrica) on the Treatment of Reflex Earache in Head and Neck Cancer.

Who this might be right for
Earache
University Hospital, Lille 42
Large-scale testing (Phase 3)Looking for participantsNCT07463573
What this trial is testing

QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Qilu Pharmaceutical Co., Ltd. 466
Testing effectiveness (Phase 2)UnknownNCT05163483
What this trial is testing

Tucidinostat Plus PD-1 Inhibitor and Bevacizumab for Advanced Esophagus Cancer, AEG, Gastric Cancer

Who this might be right for
Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma
Ruihua Xu 87
Not applicableUnknownNCT01957241
What this trial is testing

PLA for HCC and Esophageal ca Serum

Who this might be right for
Hepatocellular CarcinomaEsophageal Cancer
National Taiwan University Hospital 164
Large-scale testing (Phase 3)Study completedNCT02395705
What this trial is testing

Neoadjuvant Chemotherapy Versus Surgery Alone for Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Neoplasm
Henan Cancer Hospital 528
Not applicableStudy completedNCT05936502
What this trial is testing

Ascertaining the Radiologic Prognostic Importance of Extranodal Extension on Imaging (iENE) in Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell CarcinomaExtranodal ExtensionHuman Papilloma Virus Related Carcinoma
Head and Neck Cancer International Group 3,500
Not applicableLooking for participantsNCT07140757
What this trial is testing

Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers

Who this might be right for
Low RiskPapillary Thyroid CancerRadiofrequency Ablation
M.D. Anderson Cancer Center 50
Not applicableUnknownNCT05816629
What this trial is testing

Multiparameter Ultrasound Based-AI for the Diagnosis of Thyroid Nodules

Who this might be right for
Thyroid Nodule
Second Affiliated Hospital, Zhejiang University, School of Medicine 2,000
Large-scale testing (Phase 3)Study completedNCT03358472
What this trial is testing

Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304)

Who this might be right for
Head and Neck Cancer
Incyte Corporation 89
Early research (Phase 1)UnknownNCT03076372
What this trial is testing

A Study Evaluating MM-310 in Patients With Solid Tumors

Who this might be right for
Solid TumorsUrothelial CarcinomaGastric Carcinoma+9 more
Merrimack Pharmaceuticals 34
Not applicableUnknownNCT05644457
What this trial is testing

Exploratory Study of Early Biomarkers Allowing Dynamic Assessment of Response to Treatment in Cancers of the Head and Neck

Who this might be right for
Head and Neck Cancer
Royal Marsden NHS Foundation Trust 50
Not applicableWithdrawnNCT01153945
What this trial is testing

Association Between Cancer Cells and Normal Versus (Vs.) Low Levels of Thyroid Hormones in the Serum

Who this might be right for
Thyroid Cancer
Meir Medical Center
Not applicableNot Yet RecruitingNCT07823439
What this trial is testing

Pattern and Surgical Outcome of Papillary Thyroid Cancer at Sohag University Hospitals

Who this might be right for
Papillary Thyroid CarcinomaThyroid Cancer
Sohag University 30
Not applicableWithdrawnNCT03110939
What this trial is testing

Thoracic Surgery Combined With Intrathoracic Hyperthermic Perfusion for Advanced Lung Cancer / Esophageal Cancer

Who this might be right for
Esophageal CancerLung CancerHyperthermic Perfusion
Henan Cancer Hospital
Not applicableUnknownNCT01903239
What this trial is testing

Long Term Prospective Study Evaluating Effectiveness of Narrow Margins for Low-Risk Head and Neck Basal Cell Carcinomas

Who this might be right for
Basal Cell Carcinoma
Thomas Jefferson University 179
Testing effectiveness (Phase 2)Study completedNCT04428151
What this trial is testing

Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed After Platinum Therapy and Immunotherapy (MK-7902-009/E7080-G000-228/LEAP-009)

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Merck Sharp & Dohme LLC 408
Not applicableUnknownNCT06342739
What this trial is testing

Verbal Synchrony, Satisfaction and Decision-making in Face-to-face Consultations

Who this might be right for
Thyroid Nodule
European Institute of Oncology 60
Early research (Phase 1)Study completedNCT03739931
What this trial is testing

Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants in Advanced Malignancies

Who this might be right for
Dose Escalation: Relapsed/Refractory Solid Tumor Malignancies or LymphomaDose Expansion: Triple Negative Breast Cancer, HNSCC, Non-Hodgkins, Urothelial Cancer, Immune Checkpoint Refractory Melanoma, and NSCLC Lymphoma
ModernaTX, Inc. 134
Testing effectiveness (Phase 2)Study completedNCT04555837
What this trial is testing

Alisertib and Pembrolizumab for the Treatment of Patients With Rb-deficient Head and Neck Squamous Cell Cancer

Who this might be right for
Head and Neck Squamous Cell CarcinomaMalignant Solid Neoplasm
M.D. Anderson Cancer Center 24
Next Page